Bunnage Mark E. sold VRTX
February 11, 2026 · Form 4 insider transaction
Bunnage Mark E. sold 2,021 shares of Vertex Pharmaceuticals Incorporated at $460.43 per share, a transaction worth $930.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,021
Price
$460.43
Total value
$930.5K
InsiderBunnage Mark E.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 11, 2026
Filing dateFebruary 12, 2026
Shares owned after12,914
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.